Pages that link to "Q34733143"
Jump to navigation
Jump to search
The following pages link to Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease (Q34733143):
Displaying 50 items.
- MAO-inhibitors in Parkinson's Disease (Q24629770) (← links)
- Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress (Q24678238) (← links)
- Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease (Q26781122) (← links)
- The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease (Q28078546) (← links)
- Coaxil (tianeptine) in the treatment of depression in Parkinson's disease (Q28299302) (← links)
- Culture, gender and health care stigma: Practitioners’ response to facial masking experienced by people with Parkinson’s disease (Q30502799) (← links)
- Neuroimaging in Parkinson disease: from research setting to clinical practice (Q30868628) (← links)
- Imbalance of glial-neuronal interaction in synapses: a possible mechanism of the pathophysiology of bipolar disorder (Q33203078) (← links)
- Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson' (Q33260251) (← links)
- Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis? (Q33731267) (← links)
- Neurologists' diagnostic accuracy of depression and cognitive problems in patients with parkinsonism (Q34306196) (← links)
- Clinical aspects of palliative care in advanced Parkinson's disease (Q34457767) (← links)
- Depression in Parkinson's disease -- a review (Q34478301) (← links)
- Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's disease (Q34493954) (← links)
- Neurobiology of Depression and Anxiety in Parkinson's Disease (Q35028706) (← links)
- Neuropsychiatric non-motor aspects of Parkinson’s disease (Q35518017) (← links)
- Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease (Q35540208) (← links)
- The impact of mood disorders in neurological diseases: should neurologists be concerned? (Q35573292) (← links)
- The Effect of Cognitive Impairment on Mental Healthcare Costs for Individuals With Severe Psychiatric Illness (Q35617316) (← links)
- Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's disease (Q36227514) (← links)
- A matter of motion or an emotional matter? Management of depression in Parkinson's disease (Q36307871) (← links)
- Late-life depression: a neuropsychiatric approach (Q36390860) (← links)
- Non-motor symptoms of Parkinson's disease: diagnosis and management (Q36400926) (← links)
- Parkinson's disease and fatigue (Q36666578) (← links)
- Rumination and behavioural factors in Parkinson's disease depression (Q36698247) (← links)
- Non-motor symptoms: identification and management (Q37082141) (← links)
- The patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD (Q37129850) (← links)
- Early Parkinson's disease and non-motor issues (Q37267312) (← links)
- Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases (Q37358672) (← links)
- Transcranial direct current stimulation and repetitive transcranial magnetic stimulation in consultation-liaison psychiatry. (Q37371215) (← links)
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment (Q37449905) (← links)
- The course of depressive symptoms in early Parkinson's disease (Q37457863) (← links)
- Distant delivery of a mindfulness-based intervention for people with Parkinson's disease: the study protocol of a randomised pilot trial (Q37593613) (← links)
- Ethical perspectives on relations between industry and neuropsychiatric medicine (Q37763210) (← links)
- Imaging non-motor aspects of Parkinson's disease. (Q37796023) (← links)
- The challenge of non-motor symptoms in Parkinson's disease (Q37796036) (← links)
- Imaging Dopamine Transporters in Parkinson‘s Disease (Q37800096) (← links)
- When Parkinson’s disease patients go to sleep: specific sleep disturbances related to Parkinson’s disease (Q37874195) (← links)
- Anhedonia in Parkinson's disease: a systematic review of the literature. (Q37887678) (← links)
- Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. (Q38070888) (← links)
- Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems (Q38123275) (← links)
- Advances in non-dopaminergic treatments for Parkinson's disease (Q38218083) (← links)
- Association between 5-HTTLPR polymorphism and Parkinson's disease: a meta analysis (Q38223905) (← links)
- Prodromal non-motor symptoms of Parkinson's disease. (Q40247459) (← links)
- Implications of Circadian Rhythm in Dopamine and Mood Regulation (Q41288556) (← links)
- Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy (Q42126269) (← links)
- Neuropsychiatric phenomena associated with movement disorders (Q42373265) (← links)
- Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study (Q43142904) (← links)
- Depression and quality of life in monogenic compared to idiopathic, early-onset Parkinson's disease (Q44073890) (← links)
- Depression in Parkinson's Disease: The Contribution from Animal Studies (Q44130207) (← links)